-
Mashup Score: 1Anticoagulation Forum - 6 month(s) ago
Select Topic AC Stewardship AFib COVID-19 CVT DOACs Health Disparities PAD Periprocedural Management Thrombophilia VTE Women’s Health This feature requires an AC Forum account. Unlock AC University content by logging in or creating a free account. Explore this online educational platform today! 17 Lincoln Street Suite 2B Newton, MA 02461 USA Become a member of AC Forum and be a part of advancing excellence in thrombosis
Source: acforum.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 6Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial - PubMed - 6 month(s) ago
ClinicalTrials.gov Identifier: NCT05632445.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
How do you interpret the results of the ADALA RCT? With Left Atrial Appendage closure, 3 months of apix 2.5mg BID was better than DAPT. But trial was underpowered and many patients had history of bleeding - are they still willing to do low-dose DOAC? https://t.co/WM9eN9LtTT
-
-
Mashup Score: 3Don’t choose health insurance for 2025 until you read this - 7 month(s) ago
Health insurance choices for 2025 have changed for Medicare, healthcare.gov and employer plans, and costs have too. An update on what’s most important to consider.
Source: www.michiganmedicine.orgCategories: General Medicine News, CardiologistsTweet-
Are you starting to think about health insurance selection for 2025? If not, should you be? Check out this amazing @UM_IHPI resource from @karag https://t.co/ly8JifTXWu
-
-
Mashup Score: 6Pharmacist Use of a Population Management Dashboard for Safe Anticoagulant Prescribing: Evaluation of a Nationwide Implementation Effort - PubMed - 8 month(s) ago
Early adoption of the DOAC population management tool dashboard was associated with decreased rates of off-label DOAC dosing prescription and reduced bleeding. Following adoption of the DOAC population management tool dashboard, all sites experienced reductions in venous thromboembolism and stroke e …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
To read more about this analysis, check out the full manuscript at https://t.co/wPciPnIIBE @AAllenPharmD @pspoutz @DorschMike @JeremySussman
-
-
Mashup Score: 0Impact of a Direct Oral Anticoagulant Population Management Tool on Anticoagulation Therapy Monitoring in Clinical Practice - PubMed - 8 month(s) ago
Background: The optimal monitoring and follow-up strategy for long-term direct oral anticoagulant (DOAC) therapy has not been established. Historically, at our medical center, DOAC patients were referred to a clinical pharmacy specialist managed anticoagulation clinic (AC) for monitoring via …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
Other analyses from the @VeteransHealth have found that use of this population management dashboard increased pharmacist efficiency and impact, allowing them to make more medication interventions during each working day. https://t.co/49IAjZAX5D https://t.co/74No9ChJM5
-
-
Mashup Score: 3
There was rapid and sustained implementation and adoption of a population health dashboard for evidence-based anticoagulant prescribing across the national United States Veterans Health Administration health system. The impact of this tool on clinical outcomes and strategies to replicate this care m …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
We have previously shown how rapidly this tool was adopted nation-wide within @VeteransHealth. https://t.co/XjVTmRuRMH @CircOutcomes @DorschMike @JeremySussman @AAllenPharmD @pspoutz https://t.co/c3Q0BeZmhK
-
-
Mashup Score: 1
A protocol developed as per PRISMA-P guideline is registered under PROSPERO ID = CRD42019122996.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
And off-label dosing of DOACs is really common! Across 18 studies, the estimated prevalence of DOAC dosing errors was 20%. https://t.co/Xb0Rn7YPCa https://t.co/207H8iQo3k
-
-
Mashup Score: 1Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry - PubMed - 8 month(s) ago
A significant minority (almost 1 in 8) of U.S. patients in the community received NOAC doses inconsistent with labeling. NOAC over- and underdosing are associated with increased risk for adverse events. (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II [ORBIT-AF II]; NCT0170 …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
But when used incorrectly, they can lead to life-threatening bleeding. In fact, off-label use of DOACs is associated with higher rates of major bleeding, hospitalization, and mortality. https://t.co/MROY5P47kc @JACCJournals https://t.co/L83KVx93xt
-
-
Mashup Score: 1
Compared with warfarin, DOACs have more favorable efficacy and safety profiles among patients with atrial fibrillation.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
DOACs are, indeed, safer than vitamin K antagonists (e.g., warfarin), including reducing the risk of intracranial hemorrhage and hemorrhagic stroke by ~50%. https://t.co/D80jz0JEQV @CircAHA https://t.co/q9rL1IWd2S
-
-
Mashup Score: 14Electronic consultation to improve care outcomes in patients with suspected and confirmed heparin-induced thrombocytopenia - 8 month(s) ago
Heparin-induced thrombocytopenia (HIT) is a complication of heparin exposure associated with high risk for morbidity and mortality. Diagnosis and management are complex due to limitations of laboratory testing and the need for nonheparin anticoagulation.
Source: www.rpthjournal.orgCategories: General Medicine News, CardiologistsTweet-
Another great example of #AnticoagulationStewardship led by @jori_may. Using electronic health record eConsults to select appropriate #cvCoag drugs in suspected #HIT reduced unnecessary bivalirudin use AND hospital length of stay! @RPTHjournal https://t.co/BtJmdYM5dy
-
RT @AnticoagForum: 🔊 Recording is now available for the "Ask the Experts" webinar. Watch here: https://t.co/8uIK2GJaLS Thank you to our am…